ribociclib
novartis
[' ribo', 'ribociclib']
the km curve everyone s been waiting for. adjuvant ribociclib for 3 years significantly improved idfs in patients with stage ii-iii hr+ bc, with 25% reduction in the risk of recurrence &amp; a 3-year idfs delta of 3.3%. #asco23 
Medical Oncologist, Research Fellow @DanaFarber | @Harvard | PhD @LaStatale | former @IEOufficiale. Interested in breast oncology, HER2, ADCs & good music.